Day: May 21, 2021

BioMarin: Clinical Development Program Update

Update for Hemophilia Associations BioMarin is pleased to update the community regarding our gene therapy clinical trial program in hemophilia A. BioMarin’s investigational gene therapy for hemophilia A has not been approved for use; it is in ongoing clinical trials evaluating its safety and efficacy.BioMarin Hemophilia Update For Patient Associations View PDF | Download PDF […]